STAT - Reporting from the frontiers of health and medicine

Health

Health

First Opinion

By Neil Prose and Ray Barfield

Business Merck to spin off new $6.5 billion firm focused on women’s health, older drugs
Health Tech New ‘real world evidence’ company leverages medical societies to produce data for pharma
Biotech This biotech just bought three failed drugs. Here’s why
Politics Democrats interrupted Trump’s State of the Union to chant about their drug pricing bill
Health Tech Chatbots are screening for the new coronavirus — and turning up cases of the flu

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

A former Taro Pharma executive is indicted in generic price-fixing probe
Pharma execs argue new Canadian regulations for setting drug prices will hurt the country
Pharmalittle: Trump claims on drug prices are mostly false; Merck to spin off old drugs into new company

Health

Health

Special Report

Health Tech

Health

Health

Health Experts envision two scenarios if the new coronavirus isn’t contained
Health In the race to develop a coronavirus treatment, Regeneron thinks it has the inside track
Business Merck to spin off new $6.5 billion firm focused on women’s health, older drugs
Health Tech Chatbots are screening for the new coronavirus — and turning up cases of the flu
First Opinion In hospitals, housekeepers are truly the ‘keepers of the house’